Cargando…
Motor phenotype is not associated with vascular dysfunction in symptomatic Huntington’s disease transgenic R6/2 (160 CAG) mice
Whereas Huntington’s disease (HD) is unequivocally a neurological disorder, a critical mass of emerging studies highlights the occurrence of peripheral pathology like cardiovascular defects in both animal models and humans. The overt impairment in cardiac function is normally expected to be associat...
Autores principales: | Di Pardo, A., Carrizzo, A., Damato, A., Castaldo, S., Amico, E., Capocci, L., Ambrosio, M., Pompeo, F., De Sanctis, C., Spinelli, C. C., Puca, A. A., Remondelli, P., Maglione, V., Vecchione, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314343/ https://www.ncbi.nlm.nih.gov/pubmed/28211486 http://dx.doi.org/10.1038/srep42797 |
Ejemplares similares
-
Nitric Oxide Dysregulation in Platelets from Patients with Advanced Huntington Disease
por: Carrizzo, Albino, et al.
Publicado: (2014) -
Impairment of blood-brain barrier is an early event in R6/2 mouse model of Huntington Disease
por: Di Pardo, Alba, et al.
Publicado: (2017) -
The longevity-associated variant of BPIFB4 improves a CXCR4-mediated striatum–microglia crosstalk preventing disease progression in a mouse model of Huntington’s disease
por: Di Pardo, Alba, et al.
Publicado: (2020) -
Stimulation of Sphingosine Kinase 1 (SPHK1) Is Beneficial in a Huntington’s Disease Pre-clinical Model
por: Di Pardo, Alba, et al.
Publicado: (2019) -
Rac1 Pharmacological Inhibition Rescues Human Endothelial Dysfunction
por: Carrizzo, Albino, et al.
Publicado: (2017)